GAITHERSBURG, Md., Sept. 15 /PRNewswire/ -- Emergent BioSolutions Inc.
today announced the appointment of Allen Shofe to the position of Vice
President of Government Affairs. In this position, Mr. Shofe will be
responsible for designing, implementing and overseeing all aspects of the
company's domestic and international government affairs initiatives.
"Allen is a versatile and highly astute government relations and public
affairs executive," said Fuad El-Hibri, CEO of Emergent BioSolutions. "His
government affairs expertise and extensive network of professional contacts
throughout the United States and Europe will prove invaluable as we continue
our efforts to become a global leader in our field."
Mr. Shofe has more than 15 years experience in government relations and
government affairs at the Federal and state levels, as well as in the
international arena. Mr. Shofe previously held the position of Director of
Federal Government Relations at Eli Lilly and Company, where he managed a
series of government initiatives, including those that focused on intellectual
property, patent law and tort reform. Mr. Shofe received his BA in
International Relations/Diplomacy at the University of Minnesota and an LL.M,
Master of Laws from the University of Leicester in the United Kingdom.
"I look forward to the opportunity to help advance Emergent BioSolutions
into a world class biopharmaceutical company," said Mr. Shofe. "This company
has such a promising future, and to be a part of its growth and success is
something I am extremely proud of."
About Emergent BioSolutions
Emergent BioSolutions Inc., formed in 2004, is dedicated to the research,
development and manufacture of novel products which harness the immune system
to treat and prevent disease. These include vaccines and related products for
prophylactic and therapeutic use against common infectious diseases and
biological weapons of mass destruction. The company currently employs more
than 450 people with facilities in Gaithersburg and Frederick, Maryland,
Lansing, Michigan, Berkshire, U.K. and Munich Germany. More information about
Emergent BioSolutions and its subsidiaries can be found at http://www.ebsi.com
SOURCE Emergent BioSolutions Inc.